Algert Global’s Collegium Pharmaceutical COLL Stock Holding History

Algert Global’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,430	Closed	-$1.07M	–	1276
2026 Q1	$1.07M	Sell	32,430 -38,210	-54%	-$1.62M	0.02%	850
2025 Q4	$3.27M	Buy	70,640 +13,630	+24%	+$570K	0.05%	578
2025 Q3	$1.99M	Buy	+57,010	New	+$1.98M	0.03%	691
2020 Q2	–	Sell	-52,441	Closed	-$856K	–	434
2020 Q1	$856K	Buy	+52,441	New	+$1.08M	0.36%	104
2019 Q2	–	Sell	-14,035	Closed	-$212K	–	350
2019 Q1	$212K	Buy	+14,035	New	+$225K	0.12%	240

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Algert Global's COLL Position: Q2 2026 in Review

Algert Global sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 32,430 shares — an estimated $1.07M sold.

Algert Global first reported a position in COLL in Q1 2019 and held it in 5 quarters. The position peaked at $3.27M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Algert Global reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Algert Global sold 32,430 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.07M.
Algert Global first reported a position in Collegium Pharmaceutical in Q1 2019 and held it in 5 quarters.
Algert Global's Collegium Pharmaceutical position peaked at $3.27M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.